SlidesetHIVViral Hepatitis and Liver DiseaseAsian Conference on Hepatitis and AIDS (ACHA) 2016Selecting the best ART for each patient (Chinese) | Corklin Steinhart, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAsian Conference on Hepatitis and AIDS (ACHA) 2016Selecting the best ART for each patient (English) | Corklin Steinhart, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016(Abstract) Next generation sequencing in routine HIV-1 resistance diagnostic - frequency of additional resistance relevant mutations in 2% and 1% population | Dr. R. EhretView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016(Abstract) Patients with pre-existent NRTI- and NNRTI-resistance have a higher risk to lose virological suppression under tenofovir/emtricitabine/rilpivirine single tablet regimen | Dr. D. Di CarloView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016(Abstract) Dolutegravir plus Ritonavir-Boosted Darunavir in Highly cART-Experienced Subjects | Dr. G. SterrantinoView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016(Abstract) Dolutegravir plus Rilpivirine in cART-Experienced Subjects: a cohort study | Dr. G. SterrantinoView Slideset
CFPCarlo Federico PernoMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016HIV in Europe 2020 – what will it look like? | Carlo Federico Perno, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016(Abstract) Potent Activity of GS-9883, a Novel Unboosted HIV-1 Integrase Strand Transfer Inhibitor (INSTI), Against Patient Isolates with INSTI-Resistance | Dr. K. WhiteView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016(Abstract) Ex vivo determination of stem cell transplantation graft-versus-HIV reservoir effects | Dr. L. HoganView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016(Abstract) Breakthrough of preexisting X4-tropic HIV after allogeneic stem-cell transplantation | Dr. J. VerheyenView Slideset
JVJens VerheyenMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016Improving PI drug resistance scores | Jens Verheyen, MD, PhDView Slideset
LVLinos VandekerckhoveMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2016PI remain important options for first line | Linos Vandekerckhove, MD, PhDView Slideset
